🦊/Investors

VIB

Foundation

Ghent · Seed–Late Stage · 5 people tracked

Find your way into VIB

821 people in our graph share verified history with the VIB team — schools, employers, funds. One of them is your warm intro.

Mike Zakunlockedknows Jérôme Van Biervliet · together at Cornell (overlapped)
knows the team · via KU Leuven
knows the team · via Organon
knows the team · via VIB
×2knows the team · via Heidelberg University
×4knows the team · via Vlerick Business School
Fox Verdict
Sign up to see your fit

Investment thesis

VIB is a Flemish life sciences research institute focused on conducting groundbreaking biomolecular research for scientific and societal benefit. It allocates most of its budget to research, with a significant share dedicated to technology transfer aimed at converting research into viable business ventures for consumer and patient benefit. Its research spans humans, plants, and microorganisms, studying normal and pathological cellular and organismal processes. Researchers are embedded within departments across four Flemish universities to foster collaboration. As a member of EU-LIFE, VIB emphasizes excellence in life sciences, dissemination of scientific knowledge to the public, and contribution to economic development.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Late Stage
HQ
Ghent, BE
Leads rounds
Follows
Instruments
Equity
Founded
1995
Tracked investments
6

Team · 5 people

from the firm's website & curated
Christine Durinxin

Part of VIB's leadership team guiding the institute's scientific and strategic direction.

Ajit Shetty· Chairman of the Board of Directors

Chairs VIB's board of directors.

Founder mafia

3 people who came through VIB went on to found or lead other companies.

What they invest in

from 6 of 6 portfolio companies

Biotech ×5Healthtech ×4Medical Devices ×2AgTech ×1AI & Machine Learning ×1Deep Tech ×1Digital Health ×1Enterprise Software ×1

HQs:Belgium×5

Investments · 6 tracked

founders shown can be your intro path
Exevirexevir.comin✓ verified

ExeVir develops multi-specific VHH antibody therapies to treat infectious diseases, immunological conditions, and oncology, with a focus on immunocompromised populations.

BiotechDeep TechDigital HealthHealthtechMedical DevicesGhent, BE

Xavier Saelens(Scientific Founder)Nico Callewaert(Scientific Founder)inMike Garrett(Chief Executive Officer)

Co-investorsV-Bio VenturesSambrinvestUCB VenturesFund+VIVES Partners

Montis Biosciencesmontisbio.comin✓ verified

Montis Biosciences develops anti-C1q antibodies that target both the complement and myeloid axes to treat neuroinflammatory, autoimmune, neurodegenerative and ophthalmic diseases, with a lead program in Guillain-Barré syndrome and a second CD93 program in lung squamous cell carcinoma.

BiotechHealthtechLeuven, BE

Federico Grossi(Clinical Advisor & Acting CMO)

Co-investorsDroia VenturesPfizer VenturesPfizer Venture Investments

MRM Healthmrmhealth.comin✓ verified

MRM Health develops microbiome-based therapeutics using a precision-engineered platform called CORAL®, which designs and manufactures live bacterial consortia to treat diseases caused by microbiome dysbiosis.

BiotechHealthtechMedical DevicesGhent, BE

Co-investorsAthosKorysQbic Fund

Protealisprotealis.comin✓ verified

Protealis breeds legume crops such as soybeans and yellow peas and develops proprietary seed coatings with nitrogen-fixing bacteria adapted to the European climate.

AgTechBiotechFoodTechGent, BE

Benjamin Laga(Co-founder & CEO)inJonas Aper(Co-founder & Director of Breeding)in

Co-investorsAgri Investment FundInnovation IndustriesKorysV-Bio VenturesEstari GroupPMV+1 more

visit www.montisbiosciences.commontisbiosciences.comin✓ verified

Montis Biosciences is a biotechnology company developing anti-C1q antibodies that target both the complement and myeloid axes to treat neuroinflammatory, autoimmune, neurodegenerative and ophthalmic diseases, with a lead program in Guillain-Barré syndrome.

BiotechHealthtechLeuven, BE

Federico Grossi(Clinical Advisor & Acting CMO)

Co-investorsDroia VenturesPfizer VenturesPfizer Venture Investments

Anetaaneta.companyMay 2023

Aneta operates an email-based AI research service that runs 15 specialized agents across academic, market, technical, and legal sources for days to produce long, citation-backed research reports.

AI & Machine LearningEnterprise SoftwareSaaS

Co-investorsPebblebedAndera PartnersBGVForbionFountain Healthcare PartnersHTGF+2 more

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has VIB made?
VIB has 6 tracked investments.
What stage does VIB invest at?
VIB invests at the Seed, Series A, Late Stage stages.
What sectors does VIB focus on?
VIB focuses on AgTech, Biotech, FoodTech.
Where is VIB located?
VIB is headquartered in Ghent, BE.
Does VIB lead rounds?
VIB typically participates in rounds rather than leading them.

Media · Podcasts & interviews

from their channel

NEW | Episode 14: Lia Martina – From pipettes to policy

VIB

NEW | Episode 12: Ayşe Candayan – Grants, genes, and grit

VIB

NEW | Episode 13: Thomas Jacobs – Transplanting, adapting, and flourishing in a new environment

VIB

NEW | Episode 11: Laurent Galibert – A lifelong mission in drug discovery

VIB

NEW | Episode 15: Inge Van Molle – What it takes to be a jack of all trades

VIB

BioImaging Core Cribs

VIB

Images

VIB photoVIB photoVIB photoVIB photoVIB photoVIB photo

Similar investors

Featured in lists